Streetbeat News

STHZF

StateHouse Holdings Inc

Industry

Medicinal and Botanical Manufacturing

Open

N/A

Mkt cap

N/A

Volume

N/A

High

N/A

P/E Ratio

N/A

52-wk high

N/A

Low

N/A

Div yield

N/A

52-wk low

N/A

StateHouse Holdings, a significant cannabis company, has filed for bankruptcy under Canada's Bankruptcy and Insolvency Act. This follows financial struggles and legal action by Pelorus Fund. Trading on the Canadian Securities Exchange has been halted, and the company may be delisted.

Portfolio Pulse from Juan Spínelli

October 11, 2024 | 4:25 pm

Pelorus Fund REIT has filed a complaint to appoint a receiver for StateHouse Holdings due to loan defaults. Despite financial challenges, StateHouse reported a 10% revenue increase in Q2 2024. The company's financial health remains precarious with a significant working capital deficiency.

Portfolio Pulse from Nicolás Jose Rodriguez

September 27, 2024 | 3:48 pm

StateHouse Holdings Inc. reported a 10% year-over-year revenue increase for Q2 2024, driven by new product launches and cost-saving measures. Despite improved financial metrics, the company faces a significant capital deficit. The stock price remained flat at $0.03.

Portfolio Pulse from Nina Zdinjak

August 30, 2024 | 2:45 pm

StateHouse Holdings Inc. (OTCQB: STHZF) reported flat revenue year-over-year for Q1 2024, with net revenues of $25.4 million. The company improved its market presence, climbing from the 8th to the 4th largest California cannabis brand operator. Retail revenues declined, while branded wholesale manufacturing and cultivation revenues increased. Gross profit and margins improved, and adjusted EBITDA turned positive. Kevin K. Albert was appointed to the board of directors.

Portfolio Pulse from Jelena Martinovic

August 01, 2024 | 12:50 pm

The Viridian Chart of the Week analyzes the relationship between financial strength and YTD stock performance of 30 MSO/SSOs. Group 1, consisting of the strongest companies, has shown significant gains, while weaker groups have underperformed. Investors are advised to focus on stronger companies like Verano, Trulieve, and Cresco, with potential targeted investments in lower strength companies with positive catalysts.

Portfolio Pulse from Viridian Capital Advisors

June 24, 2024 | 5:12 pm

The article highlights recent executive changes in the cannabis industry, including new appointments and board changes across various companies. Notable changes include Michelle Reddish's nomination as Rhode Island's first cannabis administrator, board changes at Canopy Growth Corporation, Aurora Cannabis, and others.

Portfolio Pulse from Jelena Martinovic

June 04, 2024 | 1:58 am

This 4/20, cannabis retailers anticipate record sales, with brands like MariMed's Betty’s Eddies, Cresco's High Supply, Ascend Wellness's Simply Herb, and others leading in various states. The article highlights market leaders in the East, Midwest, California, Nevada, Florida, and New York, with a focus on companies like AYR Wellness, Curaleaf Holdings, Green Thumb Industries, and Trulieve. The pre-roll segment and the competitive landscape in each state are also discussed, indicating a highly anticipated sales surge.

Portfolio Pulse from Nicolás Jose Rodriguez

April 20, 2024 | 1:54 pm

California's cannabis sector experienced a 5% sales decline in Q4 2023, with taxable sales dropping 8% to $1.25 billion. Despite rising wholesale prices, retailer margins have tightened, indicating decreased profitability. Companies like Gold Flora, StateHouse, and Weedmaps are highlighted for their market presence amidst challenges, including regulatory hurdles and the flourishing underground market. The upcoming Benzinga Cannabis Capital Conference in Florida is noted as a significant event for industry insights.

Portfolio Pulse from Nicolás Jose Rodriguez

April 09, 2024 | 1:19 pm

California's cannabis sector is experiencing a sales decline, with a recent report from Zuanic & Associates highlighting the market's consolidation potential. Leading brands with financial backing are likely to benefit. The report covers companies like Gold Flora, StateHouse, and Weedmaps, noting a 5% drop in cannabis sales to $1.05 billion in Q4 2023. The sector faces challenges such as tighter retailer margins and legal issues, despite an increase in dispensary licenses. The upcoming Benzinga Cannabis Capital Conference will feature insights from Pablo Zuanic.

Portfolio Pulse from Nicolás Jose Rodriguez

March 29, 2024 | 12:48 pm

Vice President Harris has urged the DEA to expedite the rescheduling of cannabis, a move analyzed by Zuanic & Associates as a potential turning point in national drug policy. The report covers implications of rescheduling, FDA oversight, and the effects on the cannabis industry, including banking access and stock exchange listings. Pablo Zuanic predicts a 51% chance of DEA rescheduling cannabis, which previously spurred a market surge, notably benefiting the MSOS ETF and companies like StateHouse, Columbia Care, Jushi, and AYR Wellness.

Portfolio Pulse from Nicolás Jose Rodriguez

March 21, 2024 | 3:47 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.